SPIB and BATF provide alternate determinants of IRF4 occupancy in diffuse large B-cell lymphoma linked to disease heterogeneity

Matthew A. Care(University of Leeds), Reuben Tooze(University of Leeds), Gina M. Doody(University of Leeds), Sharon Barrans(Leeds Teaching Hospitals NHS Trust), David R. Westhead(University of Leeds), Andrew Jack(University of Alberta), Nicholas A. Barnes(St James's University Hospital), Ming Wang(Wenzhou Medical University), Yuanxue Huang(Cambridge University Hospitals NHS Foundation Trust), Ming‐Qing Du(MRC Laboratory of Molecular Biology), Jon Laye(University of Leeds), Mario Cocco(University of Leeds)
Nucleic Acids Research
May 29, 2014
10.1093/nar/gku451
Cited by 64

Related Papers

Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
|The Lancet Neurology|2012|606
Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2008|605
Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)
|Blood|2007|389
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
|Nature Genetics|2015|213